Skip to main navigation Skip to search Skip to main content

Combinatorial Engineering of Proteolytically Resistant APPI Variants that Selectively Inhibit Human Mesotrypsin for Cancer Therapy

Project Details

StatusFinished
Effective start/end date1/02/20 → 31/01/23
Linkshttps://europepmc.org/grantfinder/results?gid=20-0238

Funding

  • Worldwide Cancer Research

Access Project